Orgenesis (ORGS) Insider Trading & Ownership $1.41 -0.10 (-6.56%) As of 07/8/2025 11:58 AM Eastern Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Orgenesis (NASDAQ:ORGS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.66%Number OfInsiders Buying(Last 3 Years)1Amount OfInsider Buying(Last 3 Years)$29.48KNumber OfInsiders Selling(Last 3 Years)0 Get ORGS Insider Trade Alerts Want to know when executives and insiders are buying or selling Orgenesis stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ORGS Insider Buying and Selling by Quarter Orgenesis Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails2/1/2024Jacob SafierMajor ShareholderBuy1,010$3.30$3,333.00 1/30/2024Jacob SafierMajor ShareholderBuy2,500$3.30$8,250.00 1/25/2024Jacob SafierMajor ShareholderBuy2,500$3.20$8,000.00 1/22/2024Jacob SafierMajor ShareholderBuy1,000$2.90$2,900.00 1/18/2024Jacob SafierMajor ShareholderBuy1,000$3.30$3,300.00 1/10/2024Jacob SafierMajor ShareholderBuy1,000$3.70$3,700.00 (Data available from 1/1/2013 forward) ORGS Insider Trading Activity - Frequently Asked Questions Who is on Orgenesis' Insider Roster? The list of insiders at Orgenesis includes Jacob Safier. Learn more on insiders at ORGS. What percentage of Orgenesis stock is owned by insiders? 5.66% of Orgenesis stock is owned by insiders. Learn more on ORGS's insider holdings. Which Orgenesis insiders have been buying company stock? The following insider purchased ORGS shares in the last 24 months: Jacob Safier ($29,483.00). How much insider buying is happening at Orgenesis? Insiders have purchased a total of 9,010 ORGS shares in the last 24 months for a total of $29,483.00 bought. More Insider Trading Tools from MarketBeat Related Companies MiNK Therapeutics Insider Trades Passage Bio Insider Trades SCYNEXIS Insider Trades Coeptis Therapeutics Insider Trades Tempest Therapeutics Insider Trades Cadrenal Therapeutics Insider Trades Cognition Therapeutics Insider Trades ALX Oncology Insider Trades Cara Therapeutics Insider Trades Ovid Therapeutics Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Micron Insiders Sell But Investors Should Buy, Buy, BuySizzling Insider Buys for Your High-Yield WatchlistInsider Selling at NVIDIA Could Turn Into an Opportunity The Top Insider Sells From Q2: Buy, Sell, or Hold?3 Hot Trades for Insiders, But Are They Good Buys for Investors? This page (NASDAQ:ORGS) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orgenesis Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Orgenesis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
